The tripartite interaction of TCR-peptide-MHC (TCR-pMHC) forms the basis for CTL responses against viral infections and malignancies, while maintaining auto-tolerance and averting autoimmune diseases. The gene discussed is HLA-C; the disease is viral infectious disease.